.png){kind=icon}
.png){kind=icon}
Return
Adjunctive 810 nm photobiomodulation with pharmacotherapy for trigeminal neuralgia: A randomized controlled trial in a tertiary care centre
.png){kind=icon}
PRE
AI
S
A
S
S
S
A
DOI：10.1016/j.jphotobiol.2025.113249.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• This randomized controlled trial is one of the first to investigate the effectiveness of combining 810 nm low-level laser therapy with standard medication in patients with trigeminal neuralgia from a major tertiary care centre in India. • The addition of photobiomodulation resulted in greater reductions in both pain intensity and frequency of attacks compared to pharmacotherapy alone. • Patients receiving the combined treatment experienced faster pain relief and required lower doses of systemic medication. • These results suggest that 810 nm photobiomodulation could serve as a safe, non-invasive adjunctive therapy, offering improved outcomes in the management of trigeminal neuralgia.
Keywords:
trigeminal neuralgia
low-level laser therapy
photobiomodulation
randomized controlled trial
pain management
Journal
IF:
3.7
Papers:
5.4K
Citations:
1.7W
Organization
No organization information available
Cited Papers